Medical Marijuana Reform Underway in New Jersey | CashCropToday
0 Shares 179 Views

Medical Marijuana Reform Underway in New Jersey

March 25, 2018
179 Views

(Associated Press) – New Jersey lawmakers advanced legislation Thursday that would permit doctors to authorize medical marijuana for any diagnosed condition.

Current law permits medical marijuana to be prescribed only for certain debilitating conditions.

The Assembly health committee approved the measure with Democrats supporting it and Republicans opposed. Three Democratic members didn’t vote and two Republicans abstained.

“There is no benefit in denying a patient relief,” Democratic Assemblyman Herb Conaway, who chairs the committee, said in a statement. “Medical marijuana has the potential to treat many medical conditions. If a doctor believes medical marijuana can be an effective treatment, then they should be able to prescribe it to their patients.”

Republican Assemblyman Brian Rumpf said before the vote that he had questions about whether such an expansion was supported by science. Rumpf voted against the measure.

The legislation increases the maximum amount of marijuana that can be dispensed in 30-day period from two ounces to four.

The measure also proposes a number of other changes to the state’s medical marijuana law, including authorizing a person to serve as a primary caregiver for up to two patients. That’s up from the current limitation of no more than one patient.

New Jersey Democratic Gov. Phil Murphy is pushing for legalizing recreational marijuana.

 

You may be interested

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon
Market Watch
262 views
Market Watch
262 views

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon

Editor - November 27, 2018

Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition
Global
187 views
Global
187 views

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition

Editor - November 26, 2018

Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials
Manufacturing
185 views
Manufacturing
185 views

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials

Editor - November 26, 2018

GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: